Gary Nabel
About Gary Nabel
Gary J. Nabel: Chief Innovation Officer and Director
Gary J. Nabel currently holds the position of Chief Innovation Officer and Director. With a distinguished career in the biomedical and pharmaceutical industries, Nabel brings extensive experience in vaccine research and development. His leadership roles have positioned him at the forefront of scientific innovation, emphasizing his significant contributions to various medical fields.
Gary J. Nabel: Former Sanofi Chief Scientific Officer
From 2012 to 2020, Gary J. Nabel served as the Chief Scientific Officer and Senior Vice President of Sanofi. In this role, he played a crucial part in overseeing the company's research and development initiatives. Nabel’s tenure at Sanofi was marked by significant advancements in therapeutic research, particularly in developing vaccines and antibodies targeting numerous viral infections.
Gary J. Nabel: Founding Director of NIH Vaccine Research Center
Gary J. Nabel was the founding director of the NIH's Vaccine Research Center (VRC), where he served for 14 years from 1999 to 2012. Under his leadership, the VRC made pivotal strides in vaccine research, particularly focusing on HIV, influenza, SARS, Ebola, Chikungunya, and Epstein-Barr virus. His work emphasized the development of broadly neutralizing antibodies and laid the foundation for future vaccine innovation.
Gary J. Nabel: Academic and Research Background
Gary J. Nabel’s academic and research career includes a significant tenure as an investigator at the Howard Hughes Medical Institute at the University of Michigan from 1987 to 1999. During this period, he advanced biomedical research and contributed to the scientific community with his expertise in molecular biology and immunology.
Gary J. Nabel: Board Memberships and Recognitions
Gary J. Nabel has been elected to the National Academy of Medicine and is a fellow of the American Association of Physicians and the American Academy of Arts Sciences. He received the Geoffrey Beene Builders of Science Award from Research America and previously served as the board chair for Keystone Symposia. Currently, Nabel serves on the board of Siga Technologies Inc., contributing his vast expertise to the biotechnology sector.